Valirix plc develop treatments of oncology and womens health to improve patients lives. They provide financial, scientific and commercial framework to enable a rapid translation of innovative science into clinical development.
|Admission date:||5 Apr 2020|
|14 Jun 2023||Shareholders Presentation and Q&A Session|
|5 Jun 2023||Audited Results|
|8 Mar 2023||Investor Webinar|
|2 Feb 2023||General Meeting|
|31 Aug 2022||Half-year Report|